The Annual General Meeting on 10 June 2020 resolved to increase the share capital from currently EUR 5,292,983.00 by EUR 15,878,949.00 to EUR 21,171,932.00 from company funds. The capital increase was carried out by converting a partial amount of EUR 15,878,949.00 of the other revenue reserves reported under revenue reserves in the Company’s annual balance sheet as of 31 December 2019 into share capital in return for the issue of 15,878,949 new no-par value bearer shares ("bonus shares"). The bonus shares are entitled to dividends from 1 January 2020. The Company’s shareholders are entitled to the bonus shares on the basis of their shareholdings at a ratio of 1:3, so that for every one (1) existing share, the shareholders receive an additional three (3) bonus shares.
As all shares of the Company are held in collective giro accounts, the shareholders of the Company will receive co-ownership of the global certificate deposited with Clearstream Banking AG in the amount of the bonus shares attributable to them by means of a deposit credit and will not have to take any action in respect of the acceptance of these shares.
The bonus shares will be allocated to the entitled shareholders on the basis of their holdings of old shares according to the status as of 3 August 2020 after the close of the stock exchange by means of a deposit credit. The bonus shares will receive the same ISIN / WKN as the existing shares and will be included for trading on the regulated market of the Frankfurt Stock Exchange (Prime Standard).
Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Telefon: +49 (30) 941084-0
Telefax: +49 (30) 941084-112
http://www.ezag.de
Öffentlichkeitsarbeit
Telefon: +49 (30) 941084-138
Fax: +49 (30) 941084-112
E-Mail: karolin.riehle@ezag.de
